Matthew Iverson is the Vice President of CRI Lifetree’s Salt Lake City Center , overseeing the Clinical Trial Management department and providing scientific and operational support to Lifetree's medical staff in the development of Human Abuse Liability (HAL) and early human experimental pain models to assess the efficacy of new analgesic drugs.
Mr. Iverson joined Lifetree (now CRI Lifetree) in 2009. He holds a Master's Degree in Public Health and has over 13 years of experience in drug development. He has managed multiple drug development programs from pre-IND through NDA approval and into Phase 4. He has operational experience in Quality Assurance, Monitoring, Data Management, Medical Writing, and Project Management. This includes over 70 clinical trials in areas such as pain management (acute and chronic), pain modeling, HAL, CNS, and dermatology. Mr. Iverson's clinical research operational experience supports Lifetree's ongoing commitment to our clients to consult and bring optimal value to their products through innovative protocol design and execution. His experience in project management helps ensure that each project is robustly-planned and executed, delivering a high quality clinical program to our clients.